Changes in Treatment After Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography in Patients With Prostate Cancer: A Retrospective Case Series Study

Changes in Treatment After Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography in Patients With Prostate Cancer: A Retrospective Case Series Study

Purpose The use of gallium-68 prostate-specific membrane antigen-11 positron emission tomography/computed tomography (Ga-68 PSMA-11 PET/CT) is becoming increasingly common among men with prostate cancer (PCa). However, it remains uncertain which patients will derive the most benefit, and there is a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Si Hyun Kim, Chang Wook Jeong, Minh-Tung Do, Jang Hee Han, Seung-Hwan Jeong, Hyeong Dong Yuk, Ja Hyeon Ku, Hyeon Hoe Kim, Gi Jeong Cheon, Cheol Kwak
Format:	Article
Language:	English
Published:	Korean Urological Oncology Society 2024-07-01
Series:	Journal of Urologic Oncology
Subjects:	positron emission tomography computed tomography gallium-68 prostate-specific membrane antigen -11 prostatic neoplasms lymph node cancer staging
Online Access:	http://www.e-juo.org/upload/pdf/juo-244800380019.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

High Detection Rates for Prostate-specific Membrane Antigen–avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography
by: Sarah Thomas, et al.
Published: (2025-01-01)

Diagnosis and clinical significance of prostate calcification using computed tomography
by: Seong Cheol Kim, et al.
Published: (2025-02-01)

Clinical Responses to Prostate-specific Membrane Antigen Radioguided Salvage Lymphadenectomy for Prostate Cancer Recurrence: Results from a Prospective Exploratory Trial
by: Adam B. Weiner, et al.
Published: (2024-12-01)

Case report: Malignant priapism: penile metastasis from prostate cancer with low serum PSA level
by: Zhiqiang Zhang, et al.
Published: (2025-01-01)

A comparison of routine [68Ga]Ga-PSMA-11 preparation using Locametz and Illuccix kits
by: Ivan E. Wang, et al.
Published: (2024-12-01)

Weekly versus 2-weekly versus 3-weekly docetaxel to treat metastatic castration-resistant prostate cancer
by: Hyeong Dong Yuk, et al.
Published: (2024-12-01)

Positron emission tomography tracers for synucleinopathies
by: Jie Xiang, et al.
Published: (2025-01-01)

A challenging diagnosis of prostate cancer seeding in the perineal needle-tract after transperineal biopsy: is PET-CT the imaging of choice?
by: Claudia Fede Spicchiale, et al.
Published: (2024-11-01)

Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review
by: Minseok Suh, et al.
Published: (2024-03-01)

Fluorodeoxyglucose-positron emission tomography integrated with computed tomography in suspected recurrent cervical cancer
by: Stojiljković Milica, et al.
Published: (2024-01-01)

Diagnostic Value of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in a Patient with Adrenal Involvement of Hodgkin Lymphoma
by: Doğan Köse, et al.
Published: (2016-08-01)

Positron emission tomography for phenotyping inflammation of cardiovascular diseases
by: Xiaoyun Luo, et al.
Published: (2024-12-01)

Automated Measurement of Effective Radiation Dose by <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Yujin Eom, et al.
Published: (2024-12-01)

Cinematic rendering of 18F‐DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma
by: Steven P. Rowe, et al.
Published: (2024-06-01)

A generative whole-brain segmentation model for positron emission tomography images
by: Wenbo Li, et al.
Published: (2025-02-01)

Indications and Results for Ga-68 PSMA PET/CT in Patients with Biochemical Relapse of Prostate Cancer
by: Ivan Rogić, et al.
Published: (2024-01-01)

Theranostics in Renal Cell Carcinoma—A Step Towards New Opportunities or a Dead End—A Systematic Review
by: Katarzyna Jóźwik-Plebanek, et al.
Published: (2024-12-01)

Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
by: Dae Yul Yang, et al.
Published: (2025-01-01)

Prospective Study of Dobutamine Stress Echocardiography in Comparison with 18F-fluorodeoxyglucose Positron Emission Tomography for Myocardial Viability in Ischemic Cardiomyopathy
by: Nuthalapati Rama Kumari, et al.
Published: (2024-12-01)

Role and sensitivity of Positron Emission Tomography with [18F]Fluorodeoxyglucose in diagnosis and follow-up of patients affected by chronic pulmonary aspergillosis (CPA)
by: Gianfranco Schiraldi, et al.
Published: (2018-03-01)

The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in mice
by: Rui Luo, et al.
Published: (2025-01-01)

The Evaluation of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Initial Staging in Intermediate-Risk Prostate Cancer Patients: A Retrospective Multicenter Analysis
by: Laura Evangelista, et al.
Published: (2024-12-01)

Occult prostate carcinoma with metastasis to the mandible presenting as numb chin syndrome
by: Upasana Sethi Ahuja, et al.
Published: (2021-07-01)

Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
by: Chang Wook Jeong
Published: (2024-03-01)

Patient-reported Outcome Measures and Decision Regret After Prostate-specific Membrane Antigen–targeted Radioguided Surgery for Oligorecurrent Prostate Cancer
by: Fabian Falkenbach, et al.
Published: (2024-12-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

Positron emission tomography molecular imaging for pathological visualization in multiple system atrophy
by: La Dong, et al.
Published: (2025-03-01)

Trapezoidal back projection for positron emission tomography reconstruction
by: Dóra Varnyú, et al.
Published: (2024-12-01)

Example-Based Super-Resolution Image Reconstruction for Positron Emission Tomography Using Sparse Coding
by: Xue Ren, et al.
Published: (2024-01-01)

Diagnostic Ability of Quantitative Parameters of Whole-Body Bone SPECT/CT Using a Full-Ring 360° Cadmium-Zinc-Telluride Camera for Detecting Bone Metastasis in Patients with Prostate Cancer
by: Ik Dong Yoo, et al.
Published: (2024-12-01)

Impact of 68Ga-FAPI positron emission tomography/computed tomography on staging and tumor management in patients with gastric cancer
by: Shunyu Zhang, et al.
Published: (2025-01-01)

Process Simulation of 68Ge Preparation by Medium-High Energy Cyclotrons
by: Yong LI, et al.
Published: (2024-12-01)

Severe Xanthogranulomatous prostatitis mimicking prostate cancer: a case report
by: Wael Abdo Hassan, et al.
Published: (2024-12-01)

The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men
by: Abudu EK, et al.
Published: (2025-01-01)

DRG2 levels in prostate cancer cell lines predict response to PARP inhibitor during docetaxel treatment
by: Jeong Min Lee, et al.
Published: (2025-01-01)

Prostatitis, benign prostatic hyperplasia, and prostate cancer: a bidirectional Mendelian randomization study and clinical implications for these patients’ populations
by: Yi Wang, et al.
Published: (2024-12-01)

Detecting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions Using T2w-Derived Radiomics Feature Maps in 3T Prostate MRI
by: Laura J. Jensen, et al.
Published: (2024-11-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Giant sarcoma of the prostate stroma: Clinical, radiological and histopathological analysis of a rare prostatic cancer
by: Alan de Jesus Martinez Salas, et al.
Published: (2024-11-01)